Biliary dilatation and duodenal intussusception secondary to enteric duplication cyst: MDCT diagnosis.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 18414910)

Published in Emerg Radiol on April 15, 2008

Authors

Nicholas P Morley1, Ayis T Pyrros, Vahid Yaghmai, Frank H Miller, Paul Nikolaidis

Author Affiliations

1: University of Illinois at Chicago, Chicago, IL, USA. nmorle1@uic.edu

Articles by these authors

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology (2009) 3.57

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol (2009) 3.43

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA (2010) 1.84

ACR Appropriateness Criteria® acute onset flank pain--suspicion of stone disease. Ultrasound Q (2012) 1.76

Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology (2003) 1.73

Accidental ureteral ligation during an inguinal hernia repair of patient with crossed fused renal ectopia. Clin Imaging (2002) 1.70

Peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy produce a similar short-term anatomic and functional effect. Surgery (2013) 1.70

Response to treatment series: part 2, tumor response assessment--using new and conventional criteria. AJR Am J Roentgenol (2011) 1.64

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62

ACR Appropriateness Criteria ® acute onset of scrotal pain--without trauma, without antecedent mass. Ultrasound Q (2012) 1.57

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology (2010) 1.55

ACR Appropriateness Criteria® right lower quadrant pain--suspected appendicitis. J Am Coll Radiol (2011) 1.51

Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol (2007) 1.45

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology (2008) 1.45

Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology (2009) 1.44

Cardiac imaging training in radiology residency programs: a survey of radiology chief residents. Acad Radiol (2010) 1.43

Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol (2013) 1.41

Pancreatic mucinous cystic neoplasm size using CT volumetry, spherical and ellipsoid formulas: validation study. JOP (2014) 1.38

Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol (2008) 1.33

American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas (2014) 1.30

Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas. Radiographics (2011) 1.29

Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol (2010) 1.25

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology (2011) 1.25

Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics (2008) 1.25

A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol (2007) 1.23

Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging (2010) 1.23

Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. Radiology (2008) 1.19

Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol (2009) 1.18

Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol (2006) 1.15

Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging (2012) 1.13

Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics (2011) 1.11

Assessment of liver tumor response to therapy: role of quantitative imaging. Radiographics (2013) 1.10

Imaging benign and malignant disease of the gallbladder. Radiol Clin North Am (2002) 1.09

Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging (2011) 1.08

The nonvisualized appendix: incidence of acute appendicitis when secondary inflammatory changes are absent. AJR Am J Roentgenol (2004) 1.08

Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging (2011) 1.06

Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol (2012) 1.06

Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn's disease recurrence involving the small intestine. Am J Gastroenterol (2004) 1.05

ACR Appropriateness Criteria pretreatment staging of colorectal cancer. J Am Coll Radiol (2012) 1.05

Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol (2008) 1.03

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys (2011) 1.01

In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol (2006) 1.00

Adrenal gland hemangioma. J Urol (2011) 0.99

Imaging in intestinal ischemic disorders. Radiol Clin North Am (2008) 0.99

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology (2014) 0.98

Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation (2011) 0.97

Imaging features of the less common pancreatic masses. Abdom Imaging (2013) 0.97

Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging (2009) 0.97

ACR Appropriateness Criteria® Right Lower Quadrant Pain--Suspected Appendicitis. Ultrasound Q (2015) 0.96

Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol (2006) 0.96

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol (2012) 0.96

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Hepatology (2013) 0.95

Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging (2010) 0.94

MDCT of chest, abdomen, and pelvis using attenuation-based automated tube voltage selection in combination with iterative reconstruction: an intrapatient study of radiation dose and image quality. AJR Am J Roentgenol (2013) 0.93

Adrenal imaging: a comprehensive review. Radiol Clin North Am (2012) 0.93

Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections. J Infect Dis (2010) 0.93

Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT. Radiology (2012) 0.92

Gadolinium-enhanced 3D MR angiography of renal artery stenosis: a pilot comparison of maximum intensity projection, multiplanar reformatting, and 3D volume-rendering postprocessing algorithms. Acad Radiol (2002) 0.91

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology (2012) 0.91

MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques. Acad Radiol (2011) 0.91

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology (2014) 0.90

Identification of adhesions on CT in small-bowel obstruction. Emerg Radiol (2005) 0.90

Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology (2014) 0.90

MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol (2006) 0.89

Calcified gastrointestinal stromal tumor of the sigmoid colon mimicking inspissated barium on CT. AJR Am J Roentgenol (2006) 0.89

ACR Appropriateness Criteria on colorectal cancer screening. J Am Coll Radiol (2010) 0.89

ACR Appropriateness Criteria on Crohn's disease. J Am Coll Radiol (2010) 0.88